James C. Clemmer's most recent trade in Angiodynamic Inc was a trade of 8,307 Common Stock done at an average price of $8.7 . Disclosure was reported to the exchange on July 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.69 per share. | 19 Jul 2025 | 8,307 | 879,184 (2%) | 0% | 8.7 | 72,188 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.99 per share. | 19 Jul 2025 | 3,673 | 872,529 (2%) | 0% | 9.0 | 33,020 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.69 per share. | 19 Jul 2025 | 2,982 | 876,202 (2%) | 0% | 8.7 | 25,914 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.69 per share. | 19 Jul 2025 | 344 | 887,491 (2%) | 0% | 8.7 | 2,989 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 206,253 | 206,253 | - | - | Performance Right | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 206,253 | 887,835 (2%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 6.03 per share. | 07 Oct 2024 | 20,000 | 681,582 (1%) | 0% | 6.0 | 120,600 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share. | 20 Jul 2024 | 3,372 | 634,033 (1%) | 0% | 7.1 | 24,042 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share. | 20 Jul 2024 | 2,982 | 637,405 (1%) | 0% | 7.1 | 21,262 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 19 Jul 2024 | 8,307 | 636,570 (1%) | 0% | 7.2 | 59,644 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 7,633 | 7,633 | - | - | Performance Right | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 7,466 | 7,466 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 3,817 | 640,387 (1%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 211,622 | 211,622 | - | - | Performance Right | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 207,693 | 207,693 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 105,811 | 644,877 (1%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 56,279 | 690,312 (1%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 52,378 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.40 per share. | 17 Jul 2024 | 28,730 | 661,582 (1%) | 0% | 7.4 | 212,602 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 6.70 per share. | 08 Apr 2024 | 10,000 | 539,066 (1%) | 0% | 6.7 | 67,000 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.65 per share. | 20 Jul 2023 | 3,372 | 529,066 (1%) | 0% | 8.7 | 29,168 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.74 per share. | 20 Jul 2023 | 2,982 | 532,438 (1%) | 0% | 8.7 | 26,063 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 108,871 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 31,572 | 560,638 (1%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.92 per share. | 19 Jul 2023 | 11,379 | 549,259 (1%) | 0% | 8.9 | 101,501 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.63 per share. | 14 Jul 2023 | 4,906 | 445,501 (1%) | 0% | 9.6 | 47,245 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.56 per share. | 14 Jul 2023 | 2,262 | 443,239 (1%) | 0% | 9.6 | 21,625 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 10 Oct 2022 | 10,000 | 450,407 (1%) | 0% | 15 | 150,000 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 77,530 | 77,530 | - | - | Non- Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 66,187 | 66,187 | - | - | Performance Right | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 33,094 | 440,407 (1%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 50,139 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 25,123 | 415,887 (1%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.54 per share. | 07 Jul 2022 | 8,574 | 407,313 (1%) | 0% | 20.5 | 176,110 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 22.84 per share. | 11 Jan 2022 | 10,000 | 390,764 (1%) | 0% | 22.8 | 228,400 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2021 | 40,528 | 399,695 (1%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2021 | 34,938 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.29 per share. | 12 Aug 2021 | 21,532 | 378,163 (1%) | 0% | 27.3 | 587,608 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.10 per share. | 26 Jul 2021 | 2,105 | 359,167 (0%) | 0% | 26.1 | 54,941 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 101,667 | 101,667 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 74,840 | 74,840 | - | - | Performance Right | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 37,420 | 372,503 (0%) | 0% | 0 | Common Stock |